Skip to main content
Fig. 5 | BMC Genomics

Fig. 5

From: Identification of biomarkers and therapeutic targets related to Sepsis-associated encephalopathy in rats by quantitative proteomics

Fig. 5

The western blot results of GC, Akt1, and ApoA1. The western blot shows a higher level of GC and a lower level of Akt1 and ApoA1 observed in the CLP group compared to the sham group (P < 0.05). A, B Western blot bands and quantitative analysis of GC level at 24 h in CLP and sham groups. The blots were cropped and in Additional File 8 the full-length blots are presented. C, D Western blot bands and quantitative analysis of Akt1 level at 24 h in CLP and sham groups. The blots were cropped and in Additional File 9 the full-length blots/gels are presented. E, F Western blot bands and quantitative analysis of ApoA1 level at 24 h in CLP and sham groups. The blots were cropped and the full-length blots/gels are presented in Additional File 10

Back to article page